194 related articles for article (PubMed ID: 29897684)
1. The Human Factor: The Cost of Switching from Analog to Human Insulin.
Tsai A
Diabetes Forecast; 2017 Mar; 70(2):44-47. PubMed ID: 29897684
[No Abstract] [Full Text] [Related]
2. Evidence to Avoid Overtesting and Overuse in Diabetes Mellitus and Other Diseases.
Barry K; Slawson DC; Shaughnessy AF
Am Fam Physician; 2020 Nov; 102(10):583-584. PubMed ID: 33179893
[No Abstract] [Full Text] [Related]
3. Effect of a Virtual Pharmacy Review Program: A Population Health Case Study.
Muraywid B; Butkievich LE; Myers B
J Manag Care Spec Pharm; 2020 Jan; 26(1):24-29. PubMed ID: 31880223
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide vs. sitagliptin add-on to metformin treatment for type 2 diabetes mellitus: Short-term cost-per-controlled patient in Italy.
Ferrario MG; Lizán L; Montagnoli R; Ramírez de Arellano A
Prim Care Diabetes; 2016 Jun; 10(3):220-6. PubMed ID: 26546244
[TBL] [Abstract][Full Text] [Related]
5. Diabetes News.
Regier EE; Gao HX; Close KL
J Diabetes; 2015 Nov; 7(6):749-53. PubMed ID: 26223410
[No Abstract] [Full Text] [Related]
6. Insulin Access and Affordability Working Group: Conclusions and Recommendations.
Cefalu WT; Dawes DE; Gavlak G; Goldman D; Herman WH; Van Nuys K; Powers AC; Taylor SI; Yatvin AL;
Diabetes Care; 2018 Jun; 41(6):1299-1311. PubMed ID: 29739814
[No Abstract] [Full Text] [Related]
7. A New Algorithm Dedicated to Blood Glucose Monitoring in Insulin-Treated Elderly Dependent People With Diabetes.
Grino M; Loundou A; Boucekine M; Alitta Q; Oliver C
J Diabetes Sci Technol; 2019 Mar; 13(2):410-412. PubMed ID: 30537870
[No Abstract] [Full Text] [Related]
8. Impact of a reduced error range of SMBG in insulin-treated patients in Germany.
Schnell O; Erbach M
J Diabetes Sci Technol; 2014 May; 8(3):479-82. PubMed ID: 24876609
[TBL] [Abstract][Full Text] [Related]
9. Biosimilar Insulin and Costs: What Can We Expect?
Heinemann L
J Diabetes Sci Technol; 2015 Sep; 10(2):457-62. PubMed ID: 26350722
[TBL] [Abstract][Full Text] [Related]
10. HONE IN ON THE RANGE.
Scheiner G
Diabetes Self Manag; 2015; 32(4):18-20, 23. PubMed ID: 26380396
[No Abstract] [Full Text] [Related]
11. Empagliflozin/metformin (Synjardy) for type 2 diabetes.
Med Lett Drugs Ther; 2015 Dec; 57(1484):172-4. PubMed ID: 26670554
[No Abstract] [Full Text] [Related]
12. Many older people may be overtreated for diabetes, US study finds.
Mayor S
BMJ; 2015 Jan; 350():h188. PubMed ID: 25588872
[No Abstract] [Full Text] [Related]
13. Visualization of Blood Glucose Fluctuations Using Continuous Glucose Monitoring in Patients Undergoing Hemodialysis.
Mori K; Emoto M; Abe M; Inaba M
J Diabetes Sci Technol; 2019 Mar; 13(2):413-414. PubMed ID: 30580579
[No Abstract] [Full Text] [Related]
14. Prescribing diabetes medication for cardiovascular risk reduction in patients admitted with acute coronary syndromes: a survey of cardiologists' attitudes and practice.
Slater TA; Drozd M; Palin V; Bowles C; Waduud MA; Khatib R; Ajjan RA; Wheatcroft SB
Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):194-196. PubMed ID: 31702003
[No Abstract] [Full Text] [Related]
15. Using 2nd generation basal insulins in type 2 diabetes: Costs and savings in a comparative economic analysis in Italy, based on the BRIGHT study.
Napoli R; Fanelli F; Gazzi L; Larosa M; Bitonti R; Furneri G
Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):1937-1944. PubMed ID: 32912786
[TBL] [Abstract][Full Text] [Related]
16. New insulins and insulin therapy.
Danne T; Bolinder J
Diabetes Technol Ther; 2013 Feb; 15 Suppl 1():S40-7. PubMed ID: 23441707
[No Abstract] [Full Text] [Related]
17. Regular mailing of personalized feedback reports improves glycemic control in diabetes: A randomized controlled trial.
Yin J; Luk A; Wong R; Chung H; Kong A; Ozaki R; Ma R; Chow CC; So W; Chan J
J Diabetes; 2017 May; 9(5):536-538. PubMed ID: 28083979
[No Abstract] [Full Text] [Related]
18. The Book of Adjustments.
Scheiner G
Diabetes Self Manag; 2015; 32(5):30-2. PubMed ID: 26521607
[No Abstract] [Full Text] [Related]
19. A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes.
Borah BJ; Darkow T; Bouchard J; Aagren M; Forma F; Alemayehu B
Clin Ther; 2009 Mar; 31(3):623-31. PubMed ID: 19393853
[TBL] [Abstract][Full Text] [Related]
20. Mother and daughter carrying the same KCNJ11 mutation but with a different response to switching from insulin to sulfonylurea.
Russo C; Salina A; Aloi C; Iafusco D; Lorini R; d'Annunzio G
Diabetes Res Clin Pract; 2011 Nov; 94(2):e50-2. PubMed ID: 21871684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
